44 related articles for article (PubMed ID: 38455525)
1. PYCR1 expresses in cancer-associated fibroblasts and accelerates the progression of C6 glioblastoma.
Zhang M; Bi B; Liu G; Fan X
Histol Histopathol; 2024 May; ():18762. PubMed ID: 38826151
[TBL] [Abstract][Full Text] [Related]
2. Pro-tumorigenic activity of PYCR1 in gastric cancer through regulating the PI3K/AKT signaling.
Xiao H; Huang J; Wu H; Li Y; Wang Y
Heliyon; 2024 Mar; 10(5):e26883. PubMed ID: 38455525
[TBL] [Abstract][Full Text] [Related]
3. PYCR1, BANF1, and STARD8 Expression in Gastric Carcinoma: A Clinicopathologic, Prognostic, and Immunohistochemical Study.
Harb OA; Elfeky MA; Alabiad MA; Hemeda R; Allam AS; El Hawary AT; Elbaz M; Sharaf AL; Gertallah LM; Abdelaziz AM; Shalaby AM; Alorini M; Yahia AIO; Negm M
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):102-110. PubMed ID: 37982568
[TBL] [Abstract][Full Text] [Related]
4. Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells.
Zhang J; Shang L; Jiang W; Wu W
Bioengineered; 2022 Mar; 13(3):7904-7918. PubMed ID: 35293266
[TBL] [Abstract][Full Text] [Related]
5. PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling.
Du S; Sui Y; Ren W; Zhou J; Du C
J Bioenerg Biomembr; 2021 Apr; 53(2):247-258. PubMed ID: 33689096
[TBL] [Abstract][Full Text] [Related]
6. PYCR1 is Associated with Papillary Renal Cell Carcinoma Progression.
Wang QL; Liu L
Open Med (Wars); 2019; 14():586-592. PubMed ID: 31428683
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer.
Xiao S; Yao X; Ye J; Tian X; Yin Z; Zhou L
Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194829. PubMed ID: 35654390
[TBL] [Abstract][Full Text] [Related]
8. The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study.
Santoni M; Rizzo A; Mollica V; Matrana MR; Rosellini M; Faloppi L; Marchetti A; Battelli N; Massari F
Crit Rev Oncol Hematol; 2022 Feb; 170():103596. PubMed ID: 35031442
[TBL] [Abstract][Full Text] [Related]
9. Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?
Ricci AD; Rizzo A; Rojas Llimpe FL; Di Fabio F; De Biase D; Rihawi K
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916206
[TBL] [Abstract][Full Text] [Related]
10. DNA damage response alterations in gastric cancer: knocking down a new wall.
Ricci AD; Rizzo A; Brandi G
Future Oncol; 2021 Mar; 17(8):865-868. PubMed ID: 33508962
[No Abstract] [Full Text] [Related]
11. JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation.
Zhang B; Zhang Y; Jiang X; Su H; Wang Q; Wudu M; Jiang J; Ren H; Xu Y; Liu Z; Qiu X
J Cancer; 2021; 12(4):976-987. PubMed ID: 33442397
[TBL] [Abstract][Full Text] [Related]
12. Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome.
Xiao S; Li S; Yuan Z; Zhou L
Ann Transl Med; 2020 Aug; 8(15):937. PubMed ID: 32953737
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
